Is there an Indian generic version of Mobocertinib?

Mobocertinib (Mobocertinib) is an innovative drug used to treat EGFR gene mutation-positive advanced or metastatic non-small cell lung cancer (NSCLC). By inhibiting EGFR mutations and T790M mutations, it significantly extends patient survival, improves disease control rates, and effectively manages drug resistance while maintaining relatively good safety and tolerability. This drug provides patients with new treatment hope, improves their quality of life, and brings important medical progress to patients with advanced NSCLC

There are currently no generic drugs of Mobosetinib officially marketed in India. Mobotinib is currently on the market in China, but it is not included in medical insurance. Patients need to pay for it in full, so the price is very high. Please consult the local hospital pharmacy for specific prices. Other versions include the Hong Kong version of the original drug Mobotinib, which costs around 7,000 to 8,000 yuan. The generic drug of Mobotinib is mainly a Laotian generic drug. The price is about three to four thousand yuan, which is nearly half cheaper than the original drug. The ingredients of the original drug and the generic drug are the same.

Typically, the recommended dose of mobosetinib is 160 mg taken orally daily. It can be taken with or without food, but avoid taking it with fatty foods to reduce the risk of side effects. Dosage adjustments may be necessary based on the patient's hepatic function or drug interactions.

Common side effects of mobosetinib include diarrhea, rash, fatigue, nausea, vomiting, loss of appetite, headache, etc. Although these side effects are relatively mild, some patients may experience more severe discomfort, such as liver function abnormalities or interstitial pneumonitis. Therefore, patients need to receive regular monitoring and guidance from their doctors while using the drug.